Elaris EM-COC Study (Endometriosis)
Principle Investigator: Dr. Konda Reddy M.D
Purpose:
The objective of Elaris EM-COC Study is to evaluate whether the study medication, when taken together with an approved birth control pill, may reduce moderate to severe endometriosis pain in women aged 18 to 49 years old in the United States.
What to Expect:
The study will include approximately 14 visits to a research center in your location and last a duration of 21-45 months. Eligible participants will receive all study-related care, investigational medication, and non-hormonal birth control supplies (as applicable) at no cost. In addition, eligible participants will receive compensation for time and travel. No health insurance is required.
Eligibility Criteria:
- Are a premenopausal woman, 18-49 years old
- Have had a surgical diagnosis of endometriosis
- Have moderate-to-severe endometriosis pain
- Do not use nicotine or have a history of smoking (if 33 years or older)
- Are not pregnant, actively trying to become pregnant, or breastfeeding
- Do not have hepatitis B, hepatitis C, or other liver disease
Length / Duration:
The study is divided into 3 phases: screening, treatment, and follow-up. Participation in this clinical trial lasts 21-45 months.
Location:
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Who should you contact:
Recruitment Department: (407) 350-3979
